Skip to Content

Publications Search - Abstract View

Title: Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.
Authors: Akbari MR,  Malekzadeh R,  Nasrollahzadeh D,  Amanian D,  Islami F,  Li S,  Zandvakili I,  Shakeri R,  Sotoudeh M,  Aghcheli K,  Salahi R,  Pourshams A,  Semnani S,  Boffetta P,  Dawsey SM,  Ghadirian P,  Narod SA
Journal: Oncogene
Date: 2008 Feb 21
Branches: NEB
PubMed ID: 17724471
PMC ID: not available
Abstract: The incidence of esophageal squamous cell carcinoma (ESCC) is very high among the Turkmen population of Iran. Family studies suggest a genetic component to the disease. Turkmen are ethnically homogenous and are well suited for genetic studies. A previous study from China suggested that BRCA2 might play a role in the etiology of ESCC. We screened for mutations in the coding region of the BRCA2 gene in the germline DNA of 197 Turkmen patients with ESCC. A nonsense variant, K3326X, was identified in 9 of 197 cases (4.6%) vs 2 of 254 controls (0.8%) (OR=6.0, 95% CI=1.3-28; P=0.01). This mutation leads to the loss of the C-terminal domain of the BRCA2 protein, a part of the region of interaction with the FANCD2 protein. We observed nine other BRCA2 variants in single cases only, including two deletions, and seven missense mutations. Six of these were judged to be pathogenic. In total, a suspicious deleterious BRCA2 variant was identified in 15 of 197 ESCC cases (7.6%).